From the Journals

Obesity and weight loss both linked to RA disability


 

FROM ARTHRITIS CARE & RESEARCH

“Therefore, while intentional weight loss might be expected to have direct beneficial effects with regard to physical functioning and disability, these benefits are likely to be outweighed by the more common scenario of unintentional weight loss in association with greater severity of chronic illness,” they wrote. Indeed, one of the two registries used in the study had previously found a strong correlation between weight loss and early risk of death.

They argued that this therefore still supported – rather than refuted – the accepted view that intentional weight loss was an important way to limit disability in people with rheumatoid arthritis.

One limitation of the study was the use of BMI to measure adiposity, which the authors suggested may not have been an accurate surrogate in people with chronic disease. They also acknowledged that measures of disease activity may be different between obese and nonobese patients, and adjusting for this was challenging.

Three authors acknowledged receiving grand awards from the U.S. Department of Veterans Affairs. No conflicts of interest were declared.

SOURCE: Baker J et al. Arthritis Care Res. 2018 Apr 30. doi: 10.1002/acr.23579.

Pages

Recommended Reading

Few acutely ill hospitalized patients receive VTE prophylaxis
MDedge Rheumatology
2018 FNIH Lurie Prize awarded for DNA immune response discovery
MDedge Rheumatology
Reassurance for women taking certolizumab during pregnancy
MDedge Rheumatology
AbbVie, Samsung Bioepis settle suits with delayed U.S. entry for adalimumab biosimilar
MDedge Rheumatology
Dermatology practice gaps: improving medication management
MDedge Rheumatology
Upadacitinib for RA shows encouraging results in phase 3 trial
MDedge Rheumatology
MACE risk similar across arthritis subtypes
MDedge Rheumatology
FDA advisory committee recommends baricitinib 2 mg to treat rheumatoid arthritis
MDedge Rheumatology
FDA advisory committee votes to recommend update to celecoxib safety labeling
MDedge Rheumatology
Aim for remission, not low disease activity, in rheumatoid arthritis
MDedge Rheumatology

Related Articles